Country Meeting:
Prevention and control of HPV and HPV related cancers in France
The current landscape and way forward
Annecy, France – December, 2021
Meeting Objectives
- Discuss the healthcare system and prevention and control measures in France
- Review how prevention and control programs are organised within the French healthcare system
- Provide a summary of the epidemiology, burden of disease and surveillance related to HPV and HPV related cancers in France.
- Cervical cancer screening and treatment in France
- Give an overview of the current control measures in France
- Discuss successes, topical issues and challenges related to HPV screening and treatment
- Review the possible implementation of alternative screening methods and strategies such as self-sampling
- HPV vaccination in France
- Give an overview of the current HPV vaccination program
- Discuss successes, topical issues and challenges related to HPV vaccination
- Discussing the state of vaccine confidence, associated challenges and possible solutions to increase vaccine coverage rate.
- Discuss the impact of Covid-19 pandemic on vaccine confidence and reviewing change of perception, beliefs and opinions towards vaccination
- Discussing the efforts and stakeholders’ involvement in social mobilisation and creating awareness.
- Gain insight in the various stakeholder perspectives.
- Review country examples from other regions to learn from their successes and challenges.
- Discuss propositions regarding the way forward.
DAY 1 – Thursday, 2 December 2021
SESSION 1: OPENING AND OBJECTIVES
SESSION 2: SETTING THE SCENE: THE HEALTH CARE SYSTEM IN FRANCE
Chairs: Pierre Van Damme & Didier Riethmuller
- Organization of prevention and control programs within the French health care system
Roman Rouzier
(Pdf, Video) - Organization of the French Vaccination Technical Committee
Agathe Billette de Villemeur
(Pdf) - Mandatory vaccination in France
Catherine Weil-Olivier
(Pdf, Video) - Surveillance of Cancers in France
Anne-Sophie Woronoff
(Pdf, Video) - Questions & Discussions (Video)
SESSION 3: HPV EPIDEMIOLOGY AND CERVICAL CANCER SCREENING IN FRANCE
Chairs: Mario Poljak & Kate Cuschieri
- Surveillance of HPV in France
Jean-Luc Prétet
(Pdf, Video) - Cervical Cancer Screening. The transition from cytology to HPV based screening
Christine Clavel
(Pdf, Video) - Practical organization of the French Cervical Cancer Screening system
Anne Garnier
(Pdf, Video) - Challenges in cervical cancer screening programme in France
Christine Bergeron
(Pdf, Video) - Self-sampling as alternative/additional strategy in France
Caroline Lefeuvre
(Pdf) - Questions & discussion (Video)
SESSION 4: HPV VACCINATION IN FRANCE
Chairs: Eduardo Franco & Roman Rouzier
- HBV and HPV vaccine development and implementation
Pierre Coursaget
(Pdf) - HPV vaccination in France
Didier Riethmuller
(Pdf, Video) - Role of HCP in HPV vaccine hesitancy in France
Pierre Verger
(Pdf, Video) - History of the anti-vax in France
Olivier Jourdain
(Pdf, Video) - Insights into HPV vaccine confidence in France
Emilie Karafillakis
(Pdf, Video) - HPV vaccination in schools Pilot project in Guyana
Claire Grenier
(Pdf, Video) - Questions & Discussions (Video)
SESSION 5: BREAKOUT SESSION
- Breakout Sessions (All participants)
Topics:
– Steps for reinforcing cervical cancer screening
Chairs: Jean Luc Prétet & Christine Clavel
– Steps for reinforcing HPV vaccination
Chairs: Margaret Stanley & Didier Riethmuller
- Plenary feedback & concluding points (Video)
DAY 2 – Friday, 3 December 2021
- Welcome & Introduction
Alex Vorsters (University of Antwerp) (Video)
SESSION 6: TREATMENT OF CERVICAL AND HPV RELATED CANCERS
Chairs: Silvia de Sanjosé & Murat Gültekin
SESSION 7: IMPORTANT STAKEHOLDERS IN HPV PREVENTION AND CONTROL
Chairs: Heidi Larson
SESSION 8: BREAKOUT SESSION
Chairs: Christine Bergeron, Miguel Angel Pavón Ribas & TBC
- 3 breakout groups: Lessons learnt from the meeting
- Plenary Feedback (Video)
SESSION 9: CONCLUSION
Chairs: Nubia Muñoz & Alex Vorsters
- Conclusions and Concluding Remarks (Pdf)